The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy

Immune restoration disease associated with Mycobacterium tuberculosis is a complication of antiretroviral therapy seen in a subset of HIV-1 patients soon after they commence antiretroviral therapy. It is characterized by a 'paradoxical' worsening of treated tuberculosis or an 'unmaski...

Full description

Bibliographic Details
Main Authors: Oliver, B., Price, Patricia
Format: Journal Article
Published: 2011
Online Access:http://hdl.handle.net/20.500.11937/28736
_version_ 1848752616891219968
author Oliver, B.
Price, Patricia
author_facet Oliver, B.
Price, Patricia
author_sort Oliver, B.
building Curtin Institutional Repository
collection Online Access
description Immune restoration disease associated with Mycobacterium tuberculosis is a complication of antiretroviral therapy seen in a subset of HIV-1 patients soon after they commence antiretroviral therapy. It is characterized by a 'paradoxical' worsening of treated tuberculosis or an 'unmasking' of subclinical tuberculosis. As antiretroviral therapy becomes increasingly available in countries with a high prevalence of tuberculosis, this form of immune restoration disease will become more common. Here we summarize biomarkers that may illuminate immunopathogenesis and assist in diagnosis. © 2011 Future Medicine Ltd.
first_indexed 2025-11-14T08:11:28Z
format Journal Article
id curtin-20.500.11937-28736
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:11:28Z
publishDate 2011
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-287362017-09-13T15:17:09Z The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy Oliver, B. Price, Patricia Immune restoration disease associated with Mycobacterium tuberculosis is a complication of antiretroviral therapy seen in a subset of HIV-1 patients soon after they commence antiretroviral therapy. It is characterized by a 'paradoxical' worsening of treated tuberculosis or an 'unmasking' of subclinical tuberculosis. As antiretroviral therapy becomes increasingly available in countries with a high prevalence of tuberculosis, this form of immune restoration disease will become more common. Here we summarize biomarkers that may illuminate immunopathogenesis and assist in diagnosis. © 2011 Future Medicine Ltd. 2011 Journal Article http://hdl.handle.net/20.500.11937/28736 10.2217/bmm.11.16 restricted
spellingShingle Oliver, B.
Price, Patricia
The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
title The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
title_full The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
title_fullStr The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
title_full_unstemmed The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
title_short The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
title_sort search for biomarkers of immune restoration disease associated with mycobacterium tuberculosis in hiv patients beginning antiretroviral therapy
url http://hdl.handle.net/20.500.11937/28736